POLYSAN main priority is to create innovative original pharmaceutical products of high therapeutic efficacy. Currently POLYSAN is funding large number of scientific research and is targeting the medication for socially significant diseases.
Pharmaceutical product development is carried out at the high level using up-to-date approach and top process equipment and is based on quality assurance principle at all stages of development. The company devotes great care to the use of modern processes aimed at the environmental protection and natural resource saving. The whole pharmaceutical product development process from the pharmacological screening to the production commissioning is set up in line with the applicable Russian and international quality standards (GLP, GCP, GMP, ISO, etc.). Pre-clinical and clinical trials are conducted internationally with the involvement of largest medical agencies in Russia, CIS countries and South East Asia based on evidentiary medicine principles.
Work of Science Division results in entering the pharma markets of Russia, former CIS countries and South East Asia with new medicinal products for severe disease treatment.
POLYSAN products allow to improve the quality of medical services, to cut down the length of patients’ treatment and rehabilitation period, and to reduce the mortality rate for some medical conditions. For further development of its scientific potential POLYSAN is taking up a large-scale investment project, to build its own research center with everything required for advanced high-quality development of modern drugs.